{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:10:25Z","timestamp":1789992625056,"version":"4.0.1"},"reference-count":15,"publisher":"Galenos Yayinevi","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMJ"],"DOI":"10.4274\/mmj.galenos.2026.87036","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:59:07Z","timestamp":1789714747000},"page":"359-364","source":"Crossref","is-referenced-by-count":0,"title":["Cardiomegaly of Unknown Origin: Why Morphology Still Matters in the Genetic Era - A Case of Cardiac Fabry Disease"],"prefix":"10.4274","volume":"41","author":[{"given":"Igor","family":"MAKAROV","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"ROY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubov","family":"MITROFANOVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1662867","DOI":"10.3389\/fmed.2025.1662867","article-title":"Therapeutic landscape of Fabry disease: advances and challenges from classical strategies to emerging therapies","volume":"12","author":"Zhang","year":"2025","unstructured":"1. Zhang M, Wang C. Therapeutic landscape of Fabry disease: advances and challenges from classical strategies to emerging therapies. Front Med (Lausanne). 2025;12:1662867.","journal-title":"Front Med (Lausanne)"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.32756\/0869-5490-2025-2-31-36.","article-title":"Clinical phenotypes of Fabry disease in adult men and women","volume":"34","author":"Moiseev","year":"2025","unstructured":"2. Moiseev AS, Tao EA, Bulanov NM, Fedulova ER, Mershina EA, Moiseev SV. Clinical phenotypes of Fabry disease in adult men and women. Clin Pharmacol Ther. 2025;34:31-6.","journal-title":"Clin Pharmacol Ther"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1681\/ASN.2016090964","article-title":"Characterization of classical and nonclassical Fabry disease: a multicenter study","volume":"28","author":"Arends","year":"2017","unstructured":"3. Arends M, Wanner C, Hughes D, et al. Characterization of classical and nonclassical Fabry disease: a multicenter study. J Am Soc Nephrol. 2017;28:1631-41.","journal-title":"J Am Soc Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Monda E, Falco L, Palmiero G, et al. Cardiovascular involvement in Fabry's disease: new ad-vances in diagnostic strategies, outcome prediction and management. Card Fail Rev. 2023;9:e12.","DOI":"10.15420\/cfr.2023.06"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.hfc.2021.07.005","article-title":"Diagnosis and management of cardiovascular involve-ment in Fabry disease","volume":"18","author":"Rubino","year":"2022","unstructured":"5. Rubino M, Monda E, Lioncino M, et al. Diagnosis and management of cardiovascular involve-ment in Fabry disease. Heart Fail Clin. 2022;18:39-49.","journal-title":"Heart Fail Clin"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10741-014-9452-9","article-title":"Anderson-Fabry cardiomyopathy: prevalence, patho-physiology, diagnosis and treatment","volume":"20","author":"Putko","year":"2015","unstructured":"6. Putko BN, Wen K, Thompson RB, et al. Anderson-Fabry cardiomyopathy: prevalence, patho-physiology, diagnosis and treatment. Heart Fail Rev. 2015;20:179-91.","journal-title":"Heart Fail Rev"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2326409816661352","article-title":"Cardiac manifestation of Fabry disease: from hypertrophic cardiomyo-pathy to early diagnosis and treatment in patients without left ventricular hypertrophy","volume":"4","author":"Fern\u00e1ndez A","year":"2016","unstructured":"7. Fern\u00e1ndez A, Politei J. Cardiac manifestation of Fabry disease: from hypertrophic cardiomyo-pathy to early diagnosis and treatment in patients without left ventricular hypertrophy. J Inborn Errors Metab Screen. 2016;4:1-9.","journal-title":"J Inborn Errors Metab Screen"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1111\/echo.13367","article-title":"Differential diagnosis of left ventricular hypertrophy: usefulness of multimodality imaging and tissue characterization with cardiac magnetic reso-nance","volume":"33","author":"Izgi","year":"2016","unstructured":"8. Izgi C, Vassiliou V, Baksi AJ, Prasad SK. Differential diagnosis of left ventricular hypertrophy: usefulness of multimodality imaging and tissue characterization with cardiac magnetic reso-nance. Echocardiography. 2016;33:1765-8.","journal-title":"Echocardiography"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1136\/heartjnl-2019-315933","article-title":"Cardiomyopathy associated with the Ala143Thr variant of the \u03b1-galactosidase A gene","volume":"106","author":"Valtola","year":"2020","unstructured":"9. Valtola K, Nino-Quintero J, Hedman M, et al. Cardiomyopathy associated with the Ala143Thr variant of the \u03b1-galactosidase A gene. Heart. 2020;106:609-15.","journal-title":"Heart"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"650","DOI":"10.21037\/cdt-20-593","article-title":"Narrative review on Morbus Fabry: diagnosis and management of cardiac manifestations","volume":"11","author":"Linhart","year":"2021","unstructured":"10. Linhart A, Pale\u010dek T. Narrative review on Morbus Fabry: diagnosis and management of cardiac manifestations. Cardiovasc Diagn Ther. 2021;11:650-60.","journal-title":"Cardiovasc Diagn Ther"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Oder D, Liu D, Hu K, et al. \u03b1-Galactosidase A genotype N215S induces a specific cardiac variant of Fabry disease. Circ Cardiovasc Genet. 2017;10:e001691.","DOI":"10.1161\/CIRCGENETICS.116.001691"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.3390\/jcm11123522","article-title":"Unexplained left ventricular hypertrophy with symptomatic high-grade atrioven-tricular block in elderly patients: a case report","volume":"11","author":"TP","year":"2022","unstructured":"12. Yu TP, Chen JY. Unexplained left ventricular hypertrophy with symptomatic high-grade atrioven-tricular block in elderly patients: a case report. J Clin Med. 2022;11:3522.","journal-title":"J Clin Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"107809","DOI":"10.1016\/j.carpath.2025.107809","article-title":"Usefulness of elec-tron microscopy in the diagnosis of heterozygous Fabry disease with left ventricular outflow tract obstruction masquerading as hypertrophic cardiomyopathy","volume":"81","author":"Kanamori","year":"2026","unstructured":"13. Kanamori H, Yoshida T, Matsumoto H, Naruse G, Minatoguchi S, Okura H. Usefulness of elec-tron microscopy in the diagnosis of heterozygous Fabry disease with left ventricular outflow tract obstruction masquerading as hypertrophic cardiomyopathy. Cardiovasc Pathol. 2026;81:107809.","journal-title":"Cardiovasc Pathol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1023\/B:HUMP.0000036337.59404.b5","article-title":"Dependence of the heart weight on the body weight in patients with car-diovascular diseases","volume":"30","author":"YA","year":"2004","unstructured":"14. Vlasov YA, Volkov AM. Dependence of the heart weight on the body weight in patients with car-diovascular diseases. Hum Physiol. 2004;30:428-34.","journal-title":"Hum Physiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.carpath.2013.09.001","article-title":"Postmortem heart weight: relation to body size and effects of cardiovascular disease and cancer","volume":"23","author":"Kumar","year":"2014","unstructured":"15. Kumar NT, Liest\u00f8l K, L\u00f8berg EM, Reims HM, M\u00e6hlen J. Postmortem heart weight: relation to body size and effects of cardiovascular disease and cancer. Cardiovasc Pathol. 2014;23:5-11.","journal-title":"Cardiovasc Pathol"}],"container-title":["Medeniyet Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:29:06Z","timestamp":1789990146000},"score":1,"resource":{"primary":{"URL":"https:\/\/medeniyetmedicaljournal.org\/articles\/cardiomegaly-of-unknown-origin-why-morphology-still-matters-in-the-genetic-era-a-case-of-cardiac-fabry-disease\/doi\/MMJ.galenos.2026.87036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":15,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9,18]]}},"URL":"https:\/\/doi.org\/10.4274\/mmj.galenos.2026.87036","relation":{},"ISSN":["2149-2042"],"issn-type":[{"value":"2149-2042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,18]]}}}